| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |